Study:
A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin`s Disease
Rationale:
Drugs used in chemotherapy work in different ways to stop the growth of cancer
cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses
high-energy x-rays to kill cancer cells. Giving more than one drug (combination
chemotherapy) and giving them together with radiation therapy may kill more cancer cells.
Purpose:
This phase III trial is studying how well combination chemotherapy works when given
before radiation therapy and/or additional chemotherapy in treating young patients with
newly diagnosed Hodgkin`s lymphoma.
Study Status: Completed
Recruiting:
n/a
| Condition |
Intervention |
Phase |
|
Lymphoma |
Biological: filgrastim
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: prednisone
Drug: vincristine sulfate
Radiation: selective external radiation therapy |
Phase 3 |
Verified by
Children`s Oncology Group
November, 2010
Sponsored by: Children`s Oncology Group
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov identifier: NCT00302003
Study Type: Interventional
Study Design: Masking: Open Label, Primary Purpose: Treatment
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States
Frank G. Keller, MD., Study Chair